KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Inventory (2016 - 2025)

Charles River Laboratories International has reported Inventory over the past 17 years, most recently at $299.1 million for Q4 2025.

  • For Q4 2025, Inventory rose 7.38% year-over-year to $299.1 million; the TTM value through Dec 2025 reached $299.1 million, up 7.38%, while the annual FY2025 figure was $299.1 million, 7.38% up from the prior year.
  • Inventory for Q4 2025 was $299.1 million at Charles River Laboratories International, down from $302.6 million in the prior quarter.
  • Over five years, Inventory peaked at $380.3 million in Q4 2023 and troughed at $181.7 million in Q3 2021.
  • A 5-year average of $274.1 million and a median of $279.0 million in 2024 define the central range for Inventory.
  • Biggest five-year swings in Inventory: soared 48.65% in 2023 and later dropped 26.75% in 2024.
  • Year by year, Inventory stood at $199.1 million in 2021, then rose by 28.45% to $255.8 million in 2022, then surged by 48.65% to $380.3 million in 2023, then fell by 26.75% to $278.5 million in 2024, then grew by 7.38% to $299.1 million in 2025.
  • Business Quant data shows Inventory for CRL at $299.1 million in Q4 2025, $302.6 million in Q3 2025, and $279.6 million in Q2 2025.